Patent ID: 7393838
Filing Date: 2008-07-01
Classification: A61K,A61P,C07H

Abstract:
1. A pharmaceutical combination which comprises: (A) a glucopyranosyloxypyrazole derivative of the following general formula:  wherein R represents a hydrogen atom, a lower alkyl group or a group forming a prodrug; one of Q and T represents a group represented by the general formula:  wherein P represents a hydrogen atom or a group forming a prodrug, while the other represents a lower alkyl group or a halo(lower alkyl) group; R (B) at least one member selected from the group consisting of an insulin sensitivity enhancer, a glucose absorption inhibitor, a biguanide, an insulin secretion enhancer, an insulin preparation, a dipeptidyl peptidase IV inhibitor, glucagon-like peptide-1, bezafibrate, beclobrate, binifibrate, ciprofibrate, clinofibrate, clofibrate, aluminum clofibrate, clofibric acid, etofibrate, fenofibrate, gemfibrozil, nicofibrate, pirifibrate, ronifibrate, simfibrate, theofibrate, AHL-157, a β